• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IndiaChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
Pulmonology: 
  • Asthma
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
KOL Video Interview – Dr Paula Luna
Dermatology
2 min
expert video

KOL Video Interview – Dr Paula Luna

KOL Video Interview – Dr Amy Paller
Dermatology
2 min
expert video

KOL Video Interview – Dr Amy Paller

Charting the Future: Preventing the Atopic March
Dermatology
2 min
expert video

Charting the Future: Preventing the Atopic March

Charting the Future: Preventing the Atopic March
Dermatology
3 min
expert video

Charting the Future: Preventing the Atopic March

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg
Dermatology
10 min
expert video

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
Pulmonology
5 min
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
Type 2 Inflammation
46 min
expert video

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video

Pediatric Asthma Trajectory and Clinical Remission
Type 2 Inflammation
4 min
expert video

Pediatric Asthma Trajectory and Clinical Remission

Multifaceted Role of IL-13 in Airway Remodeling
Type 2 Inflammation
3 min
expert video

Multifaceted Role of IL-13 in Airway Remodeling

Mucus Plugging as a Potential Target in Asthma Management
Type 2 Inflammation
3 min
expert video

Mucus Plugging as a Potential Target in Asthma Management

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma
Type 2 Inflammation
5 min
expert video

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP
Dermatology
60 min
expert video

What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP

    1234
    ...
    8